B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

E3 ubiquitin ligases ubiquitinate target proteins

REACTOME PATHWAY
Reactome: R-HSA-88666545 genes18 compounds

The E3 ubiquitin ligases ubiquitinate target proteins pathway (Reactome ID: R-HSA-8866654) involves 5 genes and is affected by 18 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

HLA-APCNAPRKDCUBE2NVCP

Compounds Affecting E3 ubiquitin ligases ubiquitinate target proteins

#CompoundTargets HitStudies
1Astemizole Antihistamine drug now withdrawn from280
2naringin300
3Chlorhexidine299
4Perphenazine297
5Sphingosine300
6Resveratrol298
7Sertraline1,000
8Canrenone300
9Thioridazine35
10Hexachlorophene300
11Oxytetracycline300
12egcg300
13Clotrimazole296
14Demeclocycline5
15Edaravone298
16Oleanolic Acid300
17Triiodothyronine300
18Wortmannin300

About the E3 ubiquitin ligases ubiquitinate target proteins Pathway

The E3 ubiquitin ligases ubiquitinate target proteins pathway is catalogued in Reactome (ID: R-HSA-8866654) and involves 5 genes. In the BiohacksAI corpus, 18 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include HLA-A, PCNA, PRKDC, UBE2N, VCP.